"CP-165331"@en . . "For the treatment of hypertension, angina, and cluster headache prophylaxis."@en . "Avoid natural licorice."@en . . . . . . . . . . . . . . "Tarka"@en . . . . . . . . . . . . . . . . . . . . . . . . . . "Covera-hs"@en . . . . . . "Avoid excessive quantities of coffee or tea (Caffeine)."@en . . . . . . "90%"@en . . . . . . . . . . . . . . . . . . . . . . . . " "@en . . . "# Bellamy WT: P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol. 1996;36:161-83. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8725386"@en . . . "D-365"@en . "Verelan"@en . . . . . . . . . . . . . . "2.8-7.4 hours"@en . . . . . . . "Verapamilum"@en . . "Verapamil"@en . "Avoid alcohol."@en . . . . . . . . . . . "Isoptin sr"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Philippe Baudier, Arthur De Boeck, Jacques Fossion, \"Novel galenic forms of verapamil, their preparation and medicines containing said novel galenic forms.\" U.S. Patent US4859469, issued April, 1987."@en . . . . . . . . . . . "Take with food."@en . . . . " "@en . . . . "Verapamilo"@en . "approved"@en . "SID104171262"@en . "A calcium channel blocker that is a class IV anti-arrhythmia agent. [PubChem]"@en . "Approximately 70% of an administered dose is excreted as metabolites in the urine and 16% or more in the feces within 5 days. About 3% to 4% is excreted in the urine as unchanged drug."@en . "V\u00E9rapamil"@en . "Humans and other mammals"@en . . . . . . . . . . . "52-53-9"@en . . . . . . . . . . "SID124881789"@en . . . . . . . . . . . "Verapamil"@en . . . . . . . . . . . . . . . . . "LD₅₀=8 mg/kg (i.v. in mice)"@en . . . . . . . . . . . "Avoid taking with grapefruit juice."@en . . . . "90%"@en . . . "Verapamil inhibits voltage-dependent calcium channels. Specifically, its effect on L-type calcium channels in the heart causes a reduction in ionotropy and chronotropy, thuis reducing heart rate and blood pressure. Verapamil's mechanism of effect in cluster headache is thought to be linked to its calcium-channel blocker effect, but which channel subtypes are involved is presently not known."@en . . "Iproveratril "@en . . "CP-16533-1"@en . "Isoptin"@en . . . "Calan sr"@en . . . . "SID124881790"@en . . "Calan"@en . . . .